Who are Caffree's investors?

Caffree's investors include Baruch Future Ventures, Cornucopian Capital Management.

How much funding has Caffree raised?

Caffree has disclosed $4.9M raised across 1 round.

Where is Caffree headquartered?

Caffree is headquartered in Seattle, US.

Caffree

Seattle, US · Founded 2023 · Delaware corporation · 2 known investors

Find your way into Caffree

Your email: who you already know at Caffree, and who your contacts know
2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Caffree team
Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Caffree develops a powdered enzymatic system for precision decaffeination that converts caffeine into theobromine, allowing coffee brands to control caffeine levels without changing flavor. It targets coffee brands, cold brew and RTD beverage manufacturers, and co-packers, integrating into existing production equipment.

Biotech Deep Tech FoodTech

Founders & leadership

Eric Steven QuickExecutive

Aryeh GanzNamed on SEC filing

Board

Frank CurzioBoard director

Investors · 2

Baruch Future Ventureslisted by Baruch Future VenturesSan Francisco · $100K – $1M

Cornucopian Capital Managementlisted by Cornucopian Capital ManagementMontclair

Reported raises · per SEC filings

Form D private placements

$4.9M disclosed across 1 round · 2026

▶$4.9MraisedApr 2026 · 20 investors · Other

Rule 506(b)

Officers, directors & promoters on the filing

Aryeh GanzExecutive Officer, Director, Promoter
Eric Steven QuickExecutive Officer, Director
Frank CurzioDirector

Offering amount: $7.9M
Amount sold: $4.9M
First sale: Mar 2026
Incorporated: Corporation, Delaware, 2023
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

What does Caffree do?: Caffree develops a powdered enzymatic system for precision decaffeination that converts caffeine into theobromine, allowing coffee brands to control caffeine levels without changing flavor. It targets coffee brands, cold brew and RTD beverage manufacturers, and co-packers, integrating into existing production equipment.
Who are Caffree's investors?: Caffree's investors include Baruch Future Ventures, Cornucopian Capital Management.
How much funding has Caffree raised?: Caffree has disclosed $4.9M raised across 1 round.
Where is Caffree headquartered?: Caffree is headquartered in Seattle, US.